🇺🇸 PCRX — Pacira BioSciences, Inc.

Salud Mantener
← Volver

Precio actual

36,39 USD

Máx. histórico

119,27

4269 días

Caída desde máximo

-69,49%

Rango 52 semanas

18,80 – 36,67

Variación hoy

-0,03%

Cierre anterior

36,40

Rango de hoy

36,39 – 36,41

Volumen hoy

1.075.323

Peor caída histórica

-90,19%

25/02/2015 → 09/08/2024

Aún sin recuperar

Volatilidad anualizada ⓘ

50,36%

Información
Nombre completo
Pacira BioSciences, Inc.
Divisa
USD
Mercado
NasdaqGS
Sector
Salud
Industria
Drug Manufacturers - Specialty & Generic
Empleados
825
PER ⓘ
103,97 (puede no estar actualizado)
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
33,57 USD (puede no estar actualizado)
Primera cotización
03/02/2011
Precio actualizado
hace 18 horas
Sobre la empresa

Pacira BioSciences, Inc. engages in the development, manufacture, marketing, distribution, and sale of non-opioid pain management and regenerative health solutions to healthcare practitioners in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension for postsurgical pain management; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension indicated for the management of osteoarthritis and knee pain; and iovera system, a non-opioid handheld cryoanalgesia device used to deliver controlled doses of cold temperature to targeted nerves to produce neurolytic block that interrupts the pain-transmitting signals of a peripheral nerve. It also develops PCRX-201, a novel gene therapy vector platform enabling local administration of genetic medicines with the potential to treat large prevalent diseases like osteoarthritis. It has a development and commercialization, and supply agreement with Aratana Therapeutics, Inc. for NOCITA, a bupivacaine liposome injectable suspension product for use in animals. The company was formerly known as Pacira Pharmaceuticals, Inc. and changed its name to Pacira BioSciences, Inc. in April 2019. Pacira BioSciences, Inc. was incorporated in 2006 and is headquartered in Brisbane, California.

Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
25/02/2015 115,47 121,95 114,40 119,27 +3,61% 6,54% 685.200
24/02/2015 120,00 121,78 113,02 115,11 -2,48% 7,30% 614.400
23/02/2015 117,00 121,91 116,01 118,04 +0,61% 5,04% 563.000
20/02/2015 115,71 117,92 114,85 117,33 +1,47% 2,65% 306.600
19/02/2015 115,89 116,22 114,67 115,63 -0,17% 1,34% 328.700
18/02/2015 116,28 117,22 115,02 115,83 -0,97% 1,89% 250.800
17/02/2015 114,41 117,39 113,41 116,96 +2,65% 3,48% 281.400
13/02/2015 114,82 116,29 112,11 113,94 -0,79% 3,64% 593.600
12/02/2015 118,00 118,00 113,74 114,85 -1,11% 3,61% 382.600
11/02/2015 112,99 119,08 112,75 116,14 +3,02% 5,60% 806.700
10/02/2015 111,33 113,43 110,20 112,74 +2,54% 2,90% 307.600
09/02/2015 109,98 112,74 108,73 109,95 -0,15% 3,65% 241.900
06/02/2015 111,71 113,24 109,57 110,12 -1,46% 3,29% 271.900
05/02/2015 108,05 112,61 107,35 111,75 +4,76% 4,87% 604.000
04/02/2015 105,86 107,48 103,38 106,67 -0,61% 3,87% 301.900
03/02/2015 109,81 111,40 104,55 107,33 -1,70% 6,24% 374.000
02/02/2015 107,54 109,72 106,44 109,19 +1,71% 3,05% 546.700
30/01/2015 108,94 111,23 105,89 107,35 -1,93% 4,90% 572.400
29/01/2015 102,37 111,09 101,81 109,46 +7,80% 9,07% 725.300
28/01/2015 106,61 107,12 100,51 101,54 -4,63% 6,20% 666.600
27/01/2015 104,17 107,24 104,17 106,47 +0,98% 2,95% 409.700
26/01/2015 106,57 108,11 103,51 105,44 -1,03% 4,32% 601.100
23/01/2015 100,44 108,68 100,06 106,54 +6,10% 8,58% 1.181.200
22/01/2015 100,67 100,73 96,44 100,41 +0,59% 4,26% 346.700
21/01/2015 101,38 103,97 99,67 99,82 -2,06% 4,24% 410.900
20/01/2015 99,15 103,48 97,99 101,92 +3,28% 5,54% 498.000
16/01/2015 94,38 98,92 93,83 98,68 +4,29% 5,39% 281.200
15/01/2015 99,19 99,98 94,34 94,62 -4,00% 5,69% 600.400
14/01/2015 94,74 99,19 92,89 98,56 +2,58% 6,65% 527.400
13/01/2015 92,00 96,71 91,01 96,08 +5,69% 6,20% 632.200